Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-27

Clinical Trial Update: Atomoxetine and Huntington's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atomoxetine for Huntington's disease with chorea; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

Sponsor: University of Iowa | Conditions: Huntington Disease, Chorea | Phase 2 | Status: COMPLETED | Results posted: 2012-11-27